Overview
- A Boston Children’s Hospital team completed five of seven planned fetal embolization procedures for Vein of Galen malformation in a JAMA-reported trial cohort.
- Observed mortality fell from an expected 90% under standard postnatal care to 43% following the in utero intervention.
- Three of the five successfully treated infants survived past the neonatal period and are reported to be thriving without early neurodevelopmental delays.
- Investigators recorded unscheduled deliveries in five cases, including three preterm births occurring a mean of three days after embolization.
- Researchers emphasize feasibility but call for a larger trial to assess long-term safety, balance survival benefits against delivery risks, and confirm neurodevelopmental outcomes.